Drug Testing in Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
2019 | journal article; research paper. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Drug Testing in Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
Zhao, Z.; Li, X.; El‐Battrawy, I.; Lan, H.; Zhong, R.; Xu, Q. & Huang, M. et al. (2019)
Clinical Pharmacology & Therapeutics, 106(3) pp. 642-651. DOI: https://doi.org/10.1002/cpt.1449
Documents & Media
Details
- Authors
- Zhao, Zhihan; Li, Xin; El‐Battrawy, Ibrahim; Lan, Huan; Zhong, Rujia; Xu, Qiang; Huang, Mengying; Liao, Zhenxing; Lang, Siegfried; Zimmermann, Wolfram-Hubertus ; Borggrefe, Martin; Cyganek, Lukas ; Wieland, Thomas; Akin, Ibrahim; Zhou, Xiao‐Bo
- Issue Date
- 2019
- Journal
- Clinical Pharmacology & Therapeutics
- ISSN
- 0009-9236
- eISSN
- 1532-6535
- Language
- English
